Skip to content

Effect of Prophylactic Adjuvant Hepatic Arterial Infusion Chemotherapy on Hepatic Metastases From Colorectal Cancer After Curative Resection

Effect of Prophylactic Adjuvant Hepatic Arterial Infusion Chemotherapy on Hepatic Metastases From Colorectal Cancer After Curative Resection

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-TRC-13004167
Enrollment
Unknown
Registered
2013-12-15
Start date
2002-10-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colorectal Cancer

Interventions

Monotherapy group:6 cycles of systemic chemotherapy
Combined Therapy group:2 cycles of HAIC plus 4 cycles of systemic chemotherapy

Sponsors

First People’s Hospital affiliated to Huzhou University Medical College
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: The main inclusion criteria for the study were: histologically verified carcinoma of the colon or the rectum, no prior cancer therapy, performance status (PS) Eastern Cooperative Oncology Group (ECOG) 0-2, modest hepatic insufficiency with total bilirubin <2.0, aspartate transaminase (AST) / alanine transaminase (ALT) <4 times the upper limit of normal, absence of portal vein thrombosis, adequate bone marrow and renal function and years of age 18 to 75. During the operation, ultrasound sonography was also performed to confirm that no liver metastases were present.

Exclusion criteria

Exclusion criteria: cancer of anal canal;received preoperative cancer therapy;liver metastases detected during operation;liver metastases detected in 6 monthes after operation.

Design outcomes

Primary

MeasureTime frame
disease-free survival;

Secondary

MeasureTime frame
overall survival;liver metastases-free survival;

Countries

China

Contacts

Public ContactWenming Feng

First People’s Hospital affiliated to Huzhou University Medical College

d_fengwm@sina.com+86 13905723878

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026